Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia/lymphoma diagnosis.
Journal
Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509
Informations de publication
Date de publication:
04 06 2020
04 06 2020
Historique:
received:
29
07
2019
accepted:
22
02
2020
pubmed:
12
3
2020
medline:
10
2
2021
entrez:
12
3
2020
Statut:
ppublish
Résumé
Adult T-cell leukemia/lymphoma (ATL) is an aggressive hematological malignancy caused by human T-cell leukemia virus type-1 (HTLV-1). ATL is preceded by decades of chronic HTLV-1 infection, and the tumors carry both somatic mutations and proviral DNA integrated into the tumor genome. In order to gain insight into the oncogenic process, we used targeted sequencing to track the evolution of the malignant clone in 6 individuals, 2 to 10 years before the diagnosis of ATL. Clones of premalignant HTLV-1-infected cells bearing known driver mutations were detected in the blood up to 10 years before individuals developed acute and lymphoma subtype ATL. Six months before diagnosis, the total number and variant allele fraction of mutations increased in the blood. Peripheral blood mononuclear cells from premalignant cases (1 year prediagnosis) had significantly higher mutational burden in genes frequently mutated in ATL than did high-risk, age-matched HTLV-1 carriers who remained ATL-free after a median of 10 years of follow-up. These data show that HTLV-1-infected T-cell clones carrying key oncogenic driver mutations can be detected in cases of ATL years before the onset of symptoms. Early detection of such mutations may enable earlier and more effective intervention to prevent the development of ATL.
Identifiants
pubmed: 32160278
pii: S0006-4971(20)61974-7
doi: 10.1182/blood.2019002665
pmc: PMC7381760
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2023-2032Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 207477/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT100291MA
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 by The American Society of Hematology.
Références
N Engl J Med. 2018 Mar 29;378(13):1189-1199
pubmed: 29601269
Blood. 2012 Oct 25;120(17):3488-90
pubmed: 22955925
Semin Cancer Biol. 2014 Jun;26:89-98
pubmed: 24316494
PLoS Comput Biol. 2014 Jun 19;10(6):e1003646
pubmed: 24945836
J Infect Dis. 2019 Jan 29;219(4):562-567
pubmed: 30307560
Nat Med. 2018 Jul;24(7):1015-1023
pubmed: 29988143
Cancer. 1991 Mar 15;67(6):1622-8
pubmed: 2001551
Viruses. 2016 Jun 16;8(6):
pubmed: 27322308
PLoS Pathog. 2011 Feb 10;7(2):e1001274
pubmed: 21347344
Blood. 2018 Oct 4;132(14):1507-1518
pubmed: 30104217
Int J Cancer. 2001 Feb 15;91(4):497-9
pubmed: 11251972
Front Microbiol. 2012 Sep 10;3:322
pubmed: 22973265
Blood. 2010 Jun 3;115(22):4337-43
pubmed: 20348391
Science. 2015 May 22;348(6237):880-6
pubmed: 25999502
Blood. 2005 Jan 15;105(2):903-4
pubmed: 15632212
Blood. 2011 Mar 17;117(11):3113-22
pubmed: 21228324
Nat Rev Genet. 2018 May;19(5):269-285
pubmed: 29576615
BMC Genomics. 2016 Nov 7;17(1):880
pubmed: 27821060
Blood. 2015 Dec 10;126(24):2570-7
pubmed: 26361794
Nat Commun. 2012 May 01;3:811
pubmed: 22549840
AIDS Res Hum Retroviruses. 2013 Feb;29(2):359-64
pubmed: 22894552
Nat Genet. 2015 Nov;47(11):1304-15
pubmed: 26437031
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5
pubmed: 16407133
Cancer Causes Control. 2003 Nov;14(9):889-96
pubmed: 14682446
Blood. 1993 Oct 1;82(7):2017-24
pubmed: 8400254
Nature. 2016 May 23;534(7607):402-6
pubmed: 27281199
Blood. 2010 Aug 26;116(8):1211-9
pubmed: 20448111
Proc Natl Acad Sci U S A. 2007 May 8;104(19):8035-40
pubmed: 17483473
Cancer Sci. 2006 Jun;97(6):535-9
pubmed: 16734733
Nature. 2018 Jul;559(7714):400-404
pubmed: 29988082
Nat Med. 2006 Apr;12(4):466-72
pubmed: 16550188